US Patent Issued to Regeneron Pharmaceuticals on Aug. 4 for "Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors" (New York Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,530, issued on Aug. 4, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors" was invented by Luca Andrea Lotta (Tarrytown, N.Y.), Manuel Allen Revez Ferreira (Tarrytown, N.Y.), Aris Baras (Tarrytown, N.Y.), Parsa Akbari (Tarrytown, N.Y.) and Olukayode Sosina (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating subjects having obesity, methods of identifying subjects having an increased risk of developing obesity, methods of detecting human G-protein coupled receptor 75 variant nucleic acid molecules a...